Follow
David W. Hutton
David W. Hutton
Department of Health Management and Policy, University of MIchigan
Verified email at umich.edu - Homepage
Title
Cited by
Cited by
Year
US renal data system 2016 annual data report: epidemiology of kidney disease in the United States
R Saran, B Robinson, KC Abbott, LYC Agodoa, P Albertus, J Ayanian, ...
American journal of kidney diseases 69 (3), A7-A8, 2017
50062017
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation
JV Freeman, RP Zhu, DK Owens, AM Garber, DW Hutton, AS Go, ...
Annals of internal medicine 154 (1), 1-11, 2011
5322011
Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment: analysis from the diabetic retinopathy clinical research network …
EL Ross, DW Hutton, JD Stein, NM Bressler, LM Jampol, AR Glassman, ...
JAMA ophthalmology 134 (8), 888-896, 2016
2092016
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B
DW Hutton, D Tan, SK So, ML Brandeau
Annals of internal medicine 147 (7), 460-469, 2007
2072007
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009
N Khazeni, DW Hutton, AM Garber, N Hupert, DK Owens
Annals of Internal Medicine 151 (12), 829-839, 2009
1422009
Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma
JD Stein, DD Kim, WW Peck, SM Giannetti, DW Hutton
Archives of ophthalmology 130 (4), 497-505, 2012
1252012
Projected increase in obesity and non‐alcoholic‐steatohepatitis–related liver transplantation waitlist additions in the United States
ND Parikh, WJ Marrero, J Wang, J Steuer, EB Tapper, M Konerman, ...
Hepatology 70 (2), 487-495, 2019
1192019
Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period
D Hutton, PA Newman-Casey, M Tavag, D Zacks, J Stein
Health affairs 33 (6), 931-939, 2014
1022014
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States
PM Stranges, DW Hutton, CD Collins
Value in health 16 (2), 297-304, 2013
1002013
Cost‐effectiveness of nationwide hepatitis B catch‐up vaccination among children and adolescents in China
DW Hutton, SK So, ML Brandeau
Hepatology 51 (2), 405-414, 2010
912010
Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration
JD Stein, PA Newman-Casey, T Mrinalini, PP Lee, DW Hutton
Ophthalmology 121 (4), 936-945, 2014
852014
Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma
ND Parikh, AG Singal, DW Hutton
Cancer 123 (19), 3725-3731, 2017
812017
Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms
ND Parikh, AG Singal, DW Hutton, EB Tapper
Official journal of the American College of Gastroenterology| ACG 115 (10 …, 2020
792020
Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30
D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ...
The Lancet Global Health 7 (9), e1180-e1188, 2019
792019
Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy: secondary analysis from a diabetic retinopathy …
DW Hutton, JD Stein, NM Bressler, LM Jampol, D Browning, ...
JAMA ophthalmology 135 (6), 576-584, 2017
742017
Predictors of deceased donor kidney discard in the United States
WJ Marrero, AS Naik, JJ Friedewald, Y Xu, DW Hutton, MS Lavieri, ...
Transplantation 101 (7), 1690-1697, 2017
692017
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema
JD Stein, PA Newman-Casey, DD Kim, KH Nwanyanwu, MW Johnson, ...
Ophthalmology 120 (9), 1835-1842, 2013
682013
Cost-effectiveness model for hepatitis C screening and treatment: implications for Egypt and other countries with high prevalence
DD Kim, DW Hutton, AA Raouf, M Salama, A Hablas, IA Seifeldin, ...
Global public health 10 (3), 296-317, 2015
632015
Cost-effectiveness of access expansion to treatment of hepatitis C virus infection through primary care providers
T Rattay, IP Dumont, HS Heinzow, DW Hutton
Gastroenterology 153 (6), 1531-1543. e2, 2017
602017
A sustainable model for delivering high-quality, efficient cataract surgery in southern India
HG Le, JR Ehrlich, R Venkatesh, A Srinivasan, A Kolli, A Haripriya, ...
Health Affairs 35 (10), 1783-1790, 2016
572016
The system can't perform the operation now. Try again later.
Articles 1–20